HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q4 2022. The put-call ratio across all filers is 3.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,345 | +35.4% | 37,344 | +28.7% | 0.03% | +41.7% |
Q2 2023 | $2,470 | -2.9% | 29,026 | -5.6% | 0.02% | -4.0% |
Q1 2023 | $2,545 | -23.8% | 30,749 | -27.6% | 0.02% | -28.6% |
Q4 2022 | $3,341 | -99.9% | 42,485 | +1.6% | 0.04% | -2.8% |
Q3 2022 | $3,098,000 | +590.0% | 41,836 | +489.2% | 0.04% | +800.0% |
Q1 2022 | $449,000 | +19.1% | 7,100 | 0.0% | 0.00% | +33.3% |
Q4 2021 | $377,000 | -24.8% | 7,100 | 0.0% | 0.00% | -40.0% |
Q3 2021 | $501,000 | +5.9% | 7,100 | 0.0% | 0.01% | +25.0% |
Q2 2021 | $473,000 | -40.0% | 7,100 | 0.0% | 0.00% | -50.0% |
Q1 2021 | $788,000 | -16.0% | 7,100 | -10.1% | 0.01% | -11.1% |
Q4 2020 | $938,000 | +36.1% | 7,900 | 0.0% | 0.01% | +12.5% |
Q3 2020 | $689,000 | -56.7% | 7,900 | -55.5% | 0.01% | -57.9% |
Q2 2020 | $1,591,000 | -19.9% | 17,755 | -10.9% | 0.02% | -32.1% |
Q1 2020 | $1,986,000 | -17.7% | 19,932 | -5.1% | 0.03% | +3.7% |
Q4 2019 | $2,413,000 | -5.1% | 21,000 | +4.1% | 0.03% | -12.9% |
Q3 2019 | $2,544,000 | +4.8% | 20,168 | 0.0% | 0.03% | +3.3% |
Q2 2019 | $2,427,000 | +41.7% | 20,168 | +3.0% | 0.03% | +42.9% |
Q1 2019 | $1,713,000 | -5.7% | 19,581 | +7.8% | 0.02% | -16.0% |
Q4 2018 | $1,817,000 | -9.6% | 18,164 | +3.6% | 0.02% | +4.2% |
Q3 2018 | $2,010,000 | +60.7% | 17,536 | +25.7% | 0.02% | +60.0% |
Q2 2018 | $1,251,000 | +3.3% | 13,949 | -15.7% | 0.02% | 0.0% |
Q1 2018 | $1,211,000 | +17.8% | 16,549 | -6.5% | 0.02% | +25.0% |
Q4 2017 | $1,028,000 | +29.5% | 17,700 | 0.0% | 0.01% | +20.0% |
Q3 2017 | $794,000 | +13.6% | 17,700 | 0.0% | 0.01% | +11.1% |
Q2 2017 | $699,000 | -2.6% | 17,700 | 0.0% | 0.01% | 0.0% |
Q1 2017 | $718,000 | +0.8% | 17,700 | 0.0% | 0.01% | 0.0% |
Q4 2016 | $712,000 | +5.2% | 17,700 | -5.3% | 0.01% | 0.0% |
Q3 2016 | $677,000 | +24.9% | 18,700 | 0.0% | 0.01% | +28.6% |
Q2 2016 | $542,000 | -17.1% | 18,700 | 0.0% | 0.01% | -12.5% |
Q1 2016 | $654,000 | +8.5% | 18,700 | 0.0% | 0.01% | 0.0% |
Q4 2015 | $603,000 | -0.2% | 18,700 | 0.0% | 0.01% | 0.0% |
Q3 2015 | $604,000 | -21.9% | 18,700 | 0.0% | 0.01% | -11.1% |
Q2 2015 | $773,000 | -8.0% | 18,700 | 0.0% | 0.01% | -10.0% |
Q1 2015 | $840,000 | +20.0% | 18,700 | 0.0% | 0.01% | +25.0% |
Q4 2014 | $700,000 | +7.2% | 18,700 | 0.0% | 0.01% | 0.0% |
Q3 2014 | $653,000 | -1.1% | 18,700 | 0.0% | 0.01% | 0.0% |
Q2 2014 | $660,000 | +1.7% | 18,700 | -6.0% | 0.01% | 0.0% |
Q1 2014 | $649,000 | -22.6% | 19,900 | 0.0% | 0.01% | -20.0% |
Q4 2013 | $838,000 | -1.8% | 19,900 | -7.0% | 0.01% | +25.0% |
Q3 2013 | $853,000 | -3.6% | 21,400 | 0.0% | 0.01% | 0.0% |
Q2 2013 | $885,000 | – | 21,400 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |